---
title: "CalciMedica, Inc. (CALC.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CALC.US.md"
symbol: "CALC.US"
name: "CalciMedica, Inc."
industry: "制药"
---

# CalciMedica, Inc. (CALC.US)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 美股市场 |
| Website | [calcimedica.com](https://calcimedica.com) |

## Company Profile

CalciMedica, Inc.是一家临床阶段的生物制药公司，专注于开发针对由炎症和免疫过程以及直接细胞损伤引起的疾病的治疗药物。该公司的主要产品候选药物是 Auxora，这是一种静脉注射配方的小分子钙释放激活钙（CRAC）通道抑制剂，用于治疗急性胰腺炎、天冬氨酸酶诱导的胰腺毒性、急性肾损伤以及严重的 COVID-19 肺炎。它还开发 Auxora 用于治疗急性溃疡性结肠炎、创伤性脑损伤和过敏性哮喘；以及用于慢性炎症适应症的口服 CRAC 通道抑制剂。该公司总部位于加利福尼亚州拉荷亚

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.34 | 77/257 | - | - | - |
| PB | -29.68 | 223/257 | 7.01 | 3.23 | 2.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-29T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 75% |
| Overweight | 0 | 0% |
| Hold | 1 | 25% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.55 |
| Highest Target | 20.00 |
| Lowest Target | 6.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/CALC.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CALC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CALC.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.